ArticleBMC cancer2024

Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201).

Hiroo Imai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.